COPD

Research into early COPD biomarker receives critical funding
A $3.8 million grant will fund investigation into whether levels of the lung protein CC16 in childhood can predict risk of early COPD in later life.
August 21, 2025
Stefano Guerra, MD, PhD, will lead a new study that will analyze blood samples to identify a biomarker that could indicate an increased risk of contracting adult chronic obstructive pulmonary disease.
Frailty linked to higher risk of respiratory complications, death in smokers
Research associates frailty with exacerbations and mortality in COPDGene study.
August 21, 2025
Frailty
Long-term passive smoking doubles COPD risk in women
Study finds prolonged exposure to secondhand smoke leads to higher risk, more severe symptoms.
August 14, 2025
Secondhand Smoke
Sponsored
CDC respiratory virus guidance
Ascend Media
Review recommendations and updates to help prevent illness.
April 10, 2025
CDC respiratory virus guidance
Telehealth, home oxygen therapy could reduce readmissions in COPD patients
Fewer patients returned to hospitals after completing in-home combination treatment plans.
August 14, 2025
Telehealth
COPD biomarker research project receives $3.1 million grant
An AI-driven approach would integrate multimodal data and biomechanics for better diagnosis and tracking of COPD.
August 7, 2025
Examples of predicted dense emphysema binary masks for subjects with different GOLD scores. The top three rows show the predicted regions of centrilobular emphysema, and the bottom three rows show the predicted regions of paraseptal emphysema.
Study points toward potential screening test for COPD
Scientists have validated 10 metabolites that are altered in patients with COPD.
August 7, 2025
Copd Screening
Sponsored
Pulmonary drug market forecast
Ascend Media
Review analysis, trends and predictions for pulmonary drug delivery systems, 2025 to 2034.
April 10, 2025
Pulmonary drug market forecast
Positive phase 2a results for potential nebulized COPD treatment
AER0-007 is the first nebulized LABA/LAMA combination therapy in development for COPD.
July 30, 2025
Nebulizer
Companies partner to develop AI-powered respiratory databases
The datasets will start with COPD and asthma to help accelerate clinical research.
July 30, 2025
Ai Data
Astegolimab sees mixed results in dual studies
The potential biologic treatment for COPD met the primary endpoint in one trial but not in another one.
July 24, 2025
Good News Bad News
Sponsored
CDC respiratory virus guidance
Ascend Media
Review recommendations and updates to help prevent illness.
April 10, 2025
CDC respiratory virus guidance
The best and worst states for lung health, COPD
Colorado, Hawaii and New Mexico top the list of states with the best lung health.
July 24, 2025
Lung Health
The increasing impact of anxiety on older patients with COPD
Systemic review and meta-analysis of earlier studies finds one-third of older COPD patients suffer from anxiety disorders.
July 17, 2025
Anxiety
Phase 2 trial begins for novel COPD treatment
Verekitug is an antibody antagonist that targets the thymic stromal lymphopoietin receptor.
July 17, 2025
Thymic Stromal Lymphopoietin (TSLP) is a cytokine that is a key driver of the inflammatory response in major allergic and inflammatory diseases, such as COPD, where disruption of TSLP signaling has been clinically validated as an effective therapeutic strategy.
Page 1 of 17
Next Page
Most Popular
Alternative inflammatory pathways drive residual asthma exacerbations in children treated with mepolizumab
Study points toward potential screening test for COPD
Telehealth, home oxygen therapy could reduce readmissions in COPD patients
Language barriers linked to poorer asthma outcomes
Brinsupri becomes first FDA-approved therapy for NCFB
Ethris launches phase 2a clinical trial of mRNA candidate for asthma